We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Trinity Biotech Plc | TG:TRB | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
Hot Features
Premium
RNS Number:1168N
Tribal Group PLC
03 July 2003
Tribal Group plc ('the Company')
Tribal Group plc were advised on 2 July 2003 by Aviva plc that Morley Fund
Management Limited (a subsidiary of Aviva plc) has a notifiable interest in
2,161,521 ordinary shares in the Company, representing 4.11% of its issued
ordinary share capital.
Aviva plc also hold an interest in these shares.
These shares are held as follows:
Registered holders Number of shares held
BNY Norwich Union Nominees Ltd 211,000
Chase GA Group Nominees Ltd 1,465,286
Chase Nominees Ltd 81,842
CUIM Nominee Ltd 299,761
RBSTB Nominees Ltd 103,632
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLKGGGNGFVGFZM
1 Year Trinity Biotech Chart |
1 Month Trinity Biotech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
